Mega Lifesciences PCL's Total Assets for the quarter that ended in Mar. 2025 was ฿14,364 Mil.
During the past 12 months, Mega Lifesciences PCL's average Total Assets Growth Rate was -5.30% per year.
During the past 3 years, the average Total Assets Growth Rate was -1.10% per year.
During the past 5 years, the average Total Assets Growth Rate was 3.10% per year.
During the past 10 years, the average Total Assets Growth Rate was 7.40% per year.
During the past 13 years, Mega Lifesciences PCL's highest 3-Year average Total Assets Growth Rate was 33.20%. The lowest was -1.10%. And the median was 10.40%.
Mega Lifesciences PCL Total Assets Historical Data
The historical data trend for Mega Lifesciences PCL's Total Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.
Mega Lifesciences PCL's Total Assets for the fiscal year that ended in Dec. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mega Lifesciences PCL (BKK:MEGA-R) Total Assets Explanation
Note:
The Net Income data used here is four times the quarterly (Mar. 2025) data.
In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.
Total Assets is linked to total revenue through Asset Turnover.
Mega Lifesciences PCL's Asset Turnover for the quarter that ended in Mar. 2025 is
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.
Mega Lifesciences PCL Total Assets Related Terms
Thank you for viewing the detailed overview of Mega Lifesciences PCL's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.
Mega Lifesciences PCL manufactures and sells through independent distributors of health food supplements, branded prescription pharmaceutical products, over-the-counter products, herbal products, vitamins, and fast-moving consumer goods as well as provides distribution services relating to such products. The company's product portfolio consists of health food supplements, branded prescription pharmaceutical products, over-the-counter products, herbal products, vitamins, and fast-moving consumer goods. Its segments include Brands in which goods are manufactured and sold under brands owned by the group; Distribution in which the group provides logistical and marketing services for goods trading purposes and sale of goods manufactured by third parties; and OEM.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BKK:MEGA-R has been successfully added to your 